← All trials
NCT03679923
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 30, 2018
- Primary completion
- Oct 31, 2018
- Completion date
- Oct 31, 2018
- First posted
- —
- Last posted
- —
- Enrollment
- 84
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- ESM Technologies, LLCLead sponsor
- ESM Technologies, LLCStudy chair
- ESM Technologies, LLCStudy director
- QPSOverall official - principal investigator
- QPSCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.